Stockscreener 앱 받기
2.849
5.03%
-0.131
Iovance Biotherapeutics Inc 주식(IOVA)의 최신 뉴스
Activity Recap: Whats the beta of Iovance Biotherapeutics Inc stock2025 Historical Comparison & Real-Time Market Sentiment Alerts - baoquankhu1.vn
Autologous Cell Therapy Market Size to Reach US$ 44.55 Billion by 2033 | Astute Analytica - GlobeNewswire Inc.
Recap Report: Whats the beta of Iovance Biotherapeutics Inc stockGap Up & Risk Controlled Daily Trade Plans - baoquankhu1.vn
Iovance Biotherapeutics (NASDAQ:IOVA) Trading 7.4% HigherStill a Buy? - MarketBeat
IOVA Shares Jump 8% — What’s Retail Expecting? - Stocktwits
Iovance Biotherapeutics Sets Stage for Global TIL Leadership with Stock Induction Moves - StocksToTrade
Short Squeeze: Can LANDP sustain its profitability2025 Risk Factors & Verified Short-Term Plans - baoquankhu1.vn
How Investors Are Reacting To Iovance Biotherapeutics (IOVA) FDA Boost For Its TIL Cancer Platform - simplywall.st
Advanced Melanoma Pipeline Expands With 60+ Investigational Therapies and 55+ Active Developers, Reports DelveInsight - Barchart.com
Advanced Melanoma Pipeline Expands With 60+ Investigational - openPR.com
Bull Run: Is Iovance Biotherapeutics Inc showing insider buyingEarnings Performance Report & Accurate Technical Buy Alerts - baoquankhu1.vn
Assessing Iovance Biotherapeutics (IOVA) Valuation After Clinical Trial Progress And New FDA Designations - Sahm
What drives Iovance Biotherapeutics Incs stock priceTrade Entry Report & Community Consensus Stock Picks - baoquankhu1.vn
Trend Report: Will TNON benefit from seasonalityPortfolio Gains Summary & Stepwise Trade Execution Plans - baoquankhu1.vn
Dow Update: Can Iovance Biotherapeutics Inc deliver consistent EPS growthPortfolio Performance Report & Expert Curated Trade Setup Alerts - baoquankhu1.vn
Why Iovance Biotherapeutics Stock Got Mashed on Monday - MSN
Analyst Boosts Iovance’s Price Target Amid Positive Market Moves - timothysykes.com
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - The Manila Times
Iovance Biotherapeutics Stock Surges Amid Strategic Moves - StocksToTrade
Is Iovance Biotherapeutics (IOVA) A Potential Opportunity After Multi Year Share Price Slide - Sahm
Iovance Biotherapeutics (IOVA) Is Down 14.9% After Governance Scrutiny And Equity Raise Plan Is Revealed - Yahoo Finance
Biotech Iovance offers 97,710 stock options to 17 new hires at $2.22 - Stock Titan
Iovance Biotherapeutics (IOVA) Valuation Check After Amtagvi Outlook Reaffirmation And Governance Concerns - Yahoo Finance
Iovance Biotherapeutics, Inc. (IOVA): A Bull Case Theory - Finviz
Iovance gets conditional Health Canada approval for Amtagvi - MSN
Aug EndMonth: Is Iovance Biotherapeutics Inc still a buy after recent gainsQuarterly Portfolio Review & Daily Growth Stock Tips - baoquankhu1.vn
The Bull Case For Iovance Biotherapeutics (IOVA) Could Change Following Reaffirmed 2025 Guidance And TIL Scale-Up - Sahm
She raised more than $1 billion for Iovance. Now, Maria Fardis has a new startup and a $200 million investment - The Business Journals
Johnson Fistel, PLLP Investigates Claims on Behalf of Long-Term Shareholders of Iovance Biotherapeutics, Inc. (IOVA), Nutex Health, Inc. (NUTX), Lantheus Holdings, Inc. (LNTH), and Molina Healthcare, Inc. (MOH) - GlobeNewswire
Moving Averages: Is Iovance Biotherapeutics Inc showing insider buying2025 Year in Review & Fast Gaining Stock Reports - baoquankhu1.vn
Published on: 2026-01-12 23:18:26 - Улправда
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Given Average Rating of "Hold" by Analysts - MarketBeat
Market Moves: How Iovance Biotherapeutics Inc stock performs in weak economyQuarterly Portfolio Report & Weekly Breakout Watchlists - Bộ Nội Vụ
Assessing Iovance Biotherapeutics (IOVA) Valuation After Revenue Guidance And 1,000 Patient Milestone - Sahm
Iovance Highlights Amtagvi Momentum and Confirms 2025 Guidance - The Globe and Mail
Why Iovance Biotherapeutics Inc. stock appeals to dividend seekersWeekly Stock Analysis & Accurate Intraday Trading Signals - Улправда
Iovance Biotherapeutics Inc. (IOVA) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Iovance Biotherapeutics, Inc. Updates Corporate Presentation - TradingView — Track All Markets
Iovance Biotherapeutics (IOVA) Stock Analysis: A Potential 219% Upside in the Biotech Arena - DirectorsTalk Interviews
Why Iovance Biotherapeutics Inc. stock remains resilientJuly 2025 Weekly Recap & Stepwise Swing Trade Plans - ulpravda.ru
Iovance Biotherapeutics (NASDAQ:IOVA) Shares Down 7.4%What's Next? - MarketBeat
Why retail investors favor Iovance Biotherapeutics Inc. stockStock Price Forecasts & Low Cost Trading Plans - ulpravda.ru
Iovance Biotherapeutics (IOVA): Promising TIL Therapy Gains Momentum Amid Funding Challenges - MSN
Iovance Biotherapeutics (NASDAQ:IOVA) Trading Down 7.1%Here's What Happened - MarketBeat
Barclays Adjusts Valuation Targets for Iovance Biotherapeutics (IOVA) Amid Biotech Sector Review - Insider Monkey
Barclays adjusts valuation targets for Iovance Biotherapeutics (IOVA) amid biotech sector review - MSN
2 Beaten-Down Stocks That Will Soar in 2026, According to Wall Street - Finviz
Will Iovance Biotherapeutics Inc. stock attract more institutional investorsCovered Call Writing & Budget Friendly Investment Plans - bollywoodhelpline.com
Iovance Biotherapeutics: Bright Prospects For 2026 (NASDAQ:IOVA) - Seeking Alpha
0.28%
2.89%
자본화:
|
볼륨(24시간):